Article Text

Download PDFPDF

1713c Epigenetics in solvent induced neurobehavioral disorders
  1. Lode Godderis1,2,
  2. Ruxandra Nagy1,3,
  3. Manosij Gosh1,
  4. Radu Duca1,
  5. Minneke Viaene1,4
  1. 1Environment and Health, Department of Public Health and Primary Care, KU Leuven, Belgium
  2. 2IDEWE, External Service for Prevention and Protection at Work, Belgium
  3. 3Department of Paediatrics, Centre for Liver, Digestive, and Metabolic Diseases, University of Groningen, University Medical Centre Groningen, The Netherlands
  4. 4Department of Neurology, St Dimpna General Hospital, 2440 Geel, Belgium

Abstract

Introduction In order to prevent neurodegenerative diseases such as chronic solvent encephalopathy (CSE), it is important to elucidate the underlying mechanism. Cells are able to respond to occupational stressors by turning on or off specific genes mediated through epigenetic alterations. Consequently, epigenetic mechanisms can play an important role in mediating the effects of solvent exposure on the development of neurobehavioral disorders.

Methods We have set-up several studies in a translational design using cell lines, mice and humans exposed to solvents and CSE patients. DNA methylation was measured with liquid chromatography coupled with tandem mass spectrometry for the assessment of 2’-deoxycytidine, 5-methyl-2’-deoxycytidine, 5-hydroxymethyl-2´-deoxycytidine, 5-formyl-2´-deoxycytidine, 5-carboxy-2´-deoxycytidine and pyrosequencing.

Results Global DNA methylation and hydroxymethylation was mostly negatively associated with solvent exposure in both in vitro as in vivo studies. DNMT1 CpG1 gene-specific methylation levels were significantly higher in CSE patients as compared to controls, associations that persisted after adjustment for age, gender, alcohol abuse, smoking, level of education and the use of psychotropic medication (p=0.004 and p=0.017, respectively). In addition, in the group of CSE patients there was a positive correlation between the duration of solvent exposure and the percentage of BDNF CpG1 methylation (rs=0.374, p=0.017), which was maintained after adjustment for age and smoking (p<0.001).

Conclusion The study of epigenetic alterations gives us the possibility to study the immediate consequences of exposure and make projections for disease development. These epigenetic marks can be used to develop a set of biomarkers and used in the follow-up of humans.

  • epigenetics
  • neurological diseases
  • solvents

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.